Found: 5
Select item for more details and to access through your institution.
Pepperpot or not?
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 4, p. 431, doi. 10.1111/bjh.12426
- By:
- Publication type:
- Article
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 2, p. 244, doi. 10.1111/j.1365-2141.2011.08615.x
- By:
- Publication type:
- Article
Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 2, p. 235, doi. 10.1111/j.1365-2141.2008.07067.x
- By:
- Publication type:
- Article
Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patients.
- Published in:
- 2007
- By:
- Publication type:
- Letter